<DOC>
	<DOCNO>NCT01282502</DOCNO>
	<brief_summary>This study combine midostaurin ( PKC412 ) radiation standard chemotherapy drug call 5-Fluorouracil ( 5-FU ) subject advanced rectal cancer . Midostaurin type kinase inhibitor work block protein associate cancer cell growth . Previous study also suggest midostaurin may help increase effectiveness radiation therapy . In research look high dose midostaurin give safely combination standard chemoradiation .</brief_summary>
	<brief_title>Midostaurin ( PKC412 ) Locally Advanced Rectal Cancer</brief_title>
	<detailed_description>Midostaurin capsule take mouth 8 week . For first 2 week midostaurin take alone ( chemoradiation ) . After 2 week standard chemoradiation add midostaurin regimen . Subjects receive midostaurin chemoradiation additional 6 week . Physical exam do weekly . Blood sample take optional tumor biopsy perform week 2 . 4-5 week complete chemoradiation midostaurin subject undergo surgery standard care . Tumor tissue surgery use research purpose . A Ct scan chest , abdomen , pelvis perform . After completion surgery , subject end study visit physical exam , blood test . CT scan chest , abdomen , pelvis perform yearly 5 year .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>4'-N-benzoylstaurosporine</mesh_term>
	<mesh_term>Staurosporine</mesh_term>
	<criteria>Adenocarcinoma rectum T3/4 N+ disease Life expectancy &gt; 3 month Normal organ marrow function Metastatic disease Pregnant breastfeeding Prior radiotherapy Receiving investigational agent History inflammatory bowel disease Active scleroderma CREST syndrome Uncontrolled intercurrent illness History different malignancy unless disease free least 5 year HIV active viral hepatitis Impaired cardiac function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>chemoradiation</keyword>
</DOC>